Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples under long-term storage

Biologicals

Volumn 33, Issue 1, 2005, Pages 9-16

  José, Marta ^a   Gajardo, Rodrigo ^a   Jorquera, Juan I ^a  

^a Instituto Grifols SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; VIRUS DNA; VIRUS RNA;

ARTICLE; FOLLOW UP; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LOW TEMPERATURE PROCEDURES; PRIORITY JOURNAL; STORAGE;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 13844281770     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biologicals.2004.10.003     Document Type: Article

References (28)

1. M.P. Busch, B.D. Rawal, M. Nowicki, E.A. Operskalski, and J.W. Mosley HCV RNA and ALT patterns in seroconverting transfusion recipients, and correlation with donor ALT and RNA Transfusion huuib 37 1997 S443
2. M.P. Busch, S.H. Kleinman, and G.J. Nemo Current and emerging infectious risks of blood transfusions JAMA 289 2003 959 962
3. G.B. Schreiber, M.P. Busch, S.H. Kleinman, and J.J. Korelitz The risk of transfusion-transmitted viral infections. The retrovirus epidemiology donor study N Engl J Med 334 1996 1685 1690
4. P. Halfon, H. Khiri, V. Gerolami, M. Bourliere, J.M. Feryn, and P. Reynier Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA J Hepatol 25 1996 307 311
5. C.M. Quan, M. Krajden, J. Zhao, and A.W. Chan High-performance liquid chromatography to assess the effect of serum storage conditions on the detection of hepatitis C virus by the polymerase chain reaction J Virol Methods 43 1992 299 308
6. M. Damen, P. Sillekens, Sjerps, R. Melsert, I. Frantzen, and H.W. Reesink Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification J Virol Methods 72 1998 175 184
7. J.T. Wang, T.H. Wang, J.C. Sheu, S.M. Lin, J.T. Lin, and D.S. Chen Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus J Clin Microbiol 30 1992 750 753
8. M. da Silva Cardoso, K. Koerner, and B. Kubanek PCR screening in the routine of blood banking of the German Red Cross blood transfusion service of Baden-Württemberg Infusionsther Transfusionsmed 25 1998 116 120
9. R. Smith, and C. Heldebrant Large scale PCR screening of pooled plasma samples for HIV-1 and HCV. Advances in transfusion safety Dev Biol Stand 102 2000 109 111
10. R.Y. Dodd, S.L. Stramer, J. Aberle-Grasse, and E. Notari Risk of hepatitis and retroviral infections among blood donors and introduction of nucleic acid testing (NAT) Dev Biol Stand 102 2000 19 27
11. J.W. Mellors, A. Munoz, J.V. Giorgi, J.B. Margolick, C.J. Tassoni, and P. Gupta Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection Ann Intern Med 126 1997 946 954
12. C.C. Ginocchio, X.P. Wang, M.H. Kaplan, G. Mulligan, D. Witt, and J.W. Romano Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma J Clin Microbiol 35 1997 2886 2893
13. S.M. Bruisten, P. Oudshoorn, P. Vanswieten, B. Boesernunnink, P. Vanaarle, and S.P. Tondreau Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT J Virol Methods 67 1997 199 207
14. G. Gessoni, P. Barin, S. Valverde, A. Giacomini, C. Di Natale, and E. Orlandini Biological qualification of blood units; considerations about the effects of sample's handling and storage on stability of nucleic acids Transfus Apheresis Sci 30 2004 197 203
15. W.K. Roth, S. Buhr, C. Drosten, and E. Seifried NAT and viral safety in blood transfusion Vox Sang 78 Suppl. 2 2000 257 259
16. H. Willkommen, I. Schmidt, and J. Lower Safety issues for plasma derivatives and benefit from NAT testing Biologicals 27 1999 325 331
17. C.B. Chew, F. Zheng, K. Byth, M. Van Asten, C. Workman, and D.E. Dwyer Comparison of three commercial assays for the quantification of plasma HIV-1 RNA from individuals with low viral loads AIDS 13 1999 1977 1978
18. C. Giachetti, J.M. Linnen, D.P. Kolk, J. Dockter, K. Gillotte-Taylor, and M. Park Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA J Clin Microbiol 40 2002 2408 2419
19. D. Paraskevis, C. Haida, N. Tassopoulos, M. Raptopoulou, D. Tsantoulas, and H. Papachristou Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA J Virol Methods 103 2002 201 212
20. D. Candotti, A. Richetin, B. Cant, J. Temple, C. Sims, and I. Reeves Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system Transfusion 43 2003 215 225
21. M. Jose, S. Curtu, R. Gajardo, and J.I. Jorquera The effect of storage at different temperatures on the stability of Hepatitis C virus RNA in plasma samples Biologicals 31 2003 1 8
22. C. Davis, A. Heath, S. Best, I. Hewlett, N. Lelie, and R. Schuurman Calibration of HIV-1 working reagents for nucleic acid amplification techniques against the 1st international standard for HIV-1 RNA J Virol Methods 107 2003 37 44
23. P. Chomcznski, and N. Sacchi Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
24. W.K. Roth, M. Weber, D. Petersen, C. Drosten, S. Buhr, and W. Sireis NAT for HBV and anti-HBc testing increase blood safety Transfusion 42 2002 869 875
25. K. Brechtbuehl, S.A. Whalley, G.M. Dusheiko, and N.A. Saunders A rapid real-time quantitative polymerase chain reaction for hepatitis B virus J Virol Methods 93 2001 105 113
26. Committee for Proprietary Medicinal Products. The introduction of nucleic acid amplification technology (NAT) for the detection of hepatitis C virus RNA in plasma pools (CPMP/BWP/390/97). Addendum to note for guidance on plasma-derived medicinal products (CPMP/BWP/269/95) 1998.
27. European Network of Official Medicines Control Laboratories, Council of Europe. Guideline for validation of Nucleic Acid Amplification Technology (NAT) for the detection of Hepatitis C Virus (HCV) RNA in plasma pools (PA/PH/OMLC(98)22, DEF) 1999.
28. G.D. Ehrlich, and S.J. Greenberg PCR-based diagnostics in infectious disease vol. 2 1994 Blackwell Scientific Publications p. 38